Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
The Core Decision (Made Before Hour 1) The side effect is real, serious, and known to me now. Patients are currently taking this drug without informed consent about a ~1-in-8,000 liver failure risk. Everything else — stock price, board pressure, legal exposure — is secondary.Read the full answer
Disclaimer: This is a strategic role-play and crisis-management framework, not legal, medical, or securities advice. In a real situation I would rely on qualified FDA/regulatory, securities, and product-liability counsel, and the company’s Chief Medical Officer and Patient Safety team.Read the full answer